Sumitomo Mitsui DS Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46M Hold
51,315
0.02% 433
2026
Q1
$3.22M Buy
51,315
+1,081
+2% +$75.3K 0.03% 420
2025
Q4
$3.33M Buy
50,234
+1,153
+2% +$74.5K 0.03% 408
2025
Q3
$3.3M Sell
49,081
-86
-0.2% -$6.81K 0.03% 395
2025
Q2
$4.29M Buy
49,167
+1,183
+2% +$92.7K 0.04% 332
2025
Q1
$3.28M Buy
47,984
+721
+2% +$58.8K 0.03% 383
2024
Q4
$3.68M Buy
47,263
+6,290
+15% +$466K 0.04% 346
2024
Q3
$2.75M Buy
40,973
+527
+1% +$43.3K 0.03% 406
2024
Q2
$4.59M Buy
40,446
+3,899
+11% +$493K 0.05% 266
2024
Q1
$5.07M Buy
36,547
+251
+0.7% +$31.6K 0.06% 242
2023
Q4
$4.5M Buy
36,296
+295
+0.8% +$30.1K 0.06% 279
2023
Q3
$3.36M Buy
36,001
+2,874
+9% +$324K 0.05% 291
2023
Q2
$4.26M Buy
33,127
+280
+0.9% +$33.9K 0.07% 239
2023
Q1
$3.82M Buy
32,847
+3,222
+11% +$361K 0.07% 235
2022
Q4
$3.35M Buy
29,625
+1,768
+6% +$194K 0.07% 241
2022
Q3
$2.24M Buy
27,857
+2,001
+8% +$169K 0.05% 307
2022
Q2
$1.93M Buy
25,856
+136
+0.5% +$12.4K 0.05% 322
2022
Q1
$3.29M Buy
25,720
+72
+0.3% +$7.88K 0.07% 237
2021
Q4
$3.44M Buy
25,648
+1,532
+6% +$220K 0.07% 232
2021
Q3
$3.3M Buy
24,116
+924
+4% +$117K 0.08% 223
2021
Q2
$2.48M Sell
23,192
-116
-0.5% -$11.1K 0.06% 284
2021
Q1
$2.09M Buy
23,308
+88
+0.4% +$8.26K 0.05% 300
2020
Q4
$2.15M Buy
23,220
+68
+0.3% +$6.07K 0.06% 279
2020
Q3
$2.38M Buy
23,152
+364
+2% +$38K 0.08% 211
2020
Q2
$2.31M Buy
22,788
+2,888
+15% +$258K 0.08% 203
2020
Q1
$1.34M Buy
19,900
+156
+0.8% +$9.71K 0.06% 277
2019
Q4
$1.08M Buy
19,744
+4
+0% +$190 0.04% 399
2019
Q3
$736K Buy
19,740
+3,444
+21% +$134K 0.03% 474
2019
Q2
$610K Sell
16,296
-42,892
-72% -$1.35M 0.02% 502
2019
Q1
$1.76M Sell
59,188
-27,136
-31% -$954K 0.03% 378
2018
Q4
$2.58M Buy
86,324
+12,488
+17% +$396K 0.05% 267
2018
Q3
$2.64M Sell
73,836
-81,464
-52% -$2.53M 0.04% 311
2018
Q2
$3.69M Sell
155,300
-5,332
-3% -$113K 0.06% 249
2018
Q1
$2.98M Buy
+160,632
New +$2.38M 0.04% 294
2017
Q4
Sell
-24,348
Closed -$297K 787
2017
Q3
$297K Sell
24,348
-2,536
-9% -$44.8K ﹤0.01% 726
2017
Q2
$491K Sell
26,884
-188
-0.7% -$3.47K 0.01% 676
2017
Q1
$573K Buy
27,072
+3,472
+15% +$67.8K 0.01% 642
2016
Q4
$352K Buy
+23,600
New +$418K 0.01% 697

Other funds holding DXCM

Sumitomo Mitsui DS Asset Management's DXCM Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management held its DexCom (DXCM) position steady in Q2 2026 at 51,315 shares worth $3.46M. The position accounts for 0.02% of the portfolio, ranked #433.

Sumitomo Mitsui DS Asset Management first reported a position in DXCM in Q4 2016 and has held it in 38 quarters since. The position peaked at $5.07M in Q1 2024. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 51,315 shares of DexCom worth $3.46M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.02% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #433 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in DexCom in Q4 2016 and has held it in 38 quarters since.
  • Sumitomo Mitsui DS Asset Management's DexCom position peaked at $5.07M in Q1 2024.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.